| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Operations | EVP, Gm Cell Therapy
1 company
De Groot Eleanor serves as an EVP, Operations at TCRT. Across recent SEC filings that breaks down to 0 buys and 3 sells. Those positions are worth an estimated $301K at current prices.
The biggest single holding is TCRT (~$301K) as EVP, Operations. The recent filings there lean toward selling, a net 66,642 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 22, 2021 | TCRT Alaunos Therapeutics, Inc. | EVP, Operations | Sell | 20,132 | $1.27 | $25,567.64 | -7.8% | -43.9% | -55.1% | |
| Jan 4, 2021 | TCRT Alaunos Therapeutics, Inc. | EVP, Gm Cell Therapy | Sell | 21,620 | $2.72 | $58,806.40 | -9.5% | - | - | |
| Jan 2, 2020 | TCRT Alaunos Therapeutics, Inc. | EVP, Gm Cell Therapy | Sell | 24,890 | $4.55 | $113,249.50 | -12.5% | - | - |